Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Sales | 9,561 | 6,877 | 5,620 | 5,083 | 3,551 |
| Gross Profit | 9,561 | 6,877 | 5,620 | 5,083 | 3,551 |
| Operating Income | 9,561 | 6,877 | 5,620 | 5,083 | 3,551 |
| Pre-tax Income | 9,561 | 6,877 | 5,620 | 5,083 | 3,551 |
| Net Income Continuous | -14,524 | -15,630 | -15,638 | -21,248 | -12,005 |
| Net Income Discontinuous | 0 | 0 | 0 | 8,090 | -4,270 |
| Net Income | $-14,524 | $-15,630 | $-15,638 | $-12,445 | $-16,275 |
| EPS Basic Total Ops | -11.88 | -20.51 | -20.51 | -20.15 | -30.23 |
| EPS Basic Continuous Ops | -11.80 | -20.48 | -20.51 | -34.40 | -22.30 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 13.10 | -7.93 |
| EPS Diluted Total Ops | -11.88 | -20.51 | -20.51 | -20.15 | -30.23 |
| EPS Diluted Continuous Ops | -11.80 | -20.48 | -20.51 | -34.40 | -22.30 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 13.10 | -7.93 |
| EBITDA(a) | $9,561 | $6,877 | $5,620 | $5,083 | $3,551 |